Regulatory & Legal

Everybody Loves Languages' CEO and CFO are taking the company private, raising questions about minority shareholder value and the firm's future strategy.

An FDA setback for its new mastitis drug prompts ImmuCell to double down on its profitable calf health franchise, First Defense®, in a major strategic shift.

The cardiac device innovator adds seasoned sales and operations executives to prepare its novel cryoablation technology for the global market.

Croatian firm Orqa is building a global network to produce one million drones annually, challenging market leaders and securing allied defense supply chains.

Tevogen's Dr. Ryan Saadi donates over $88,000 in company stock to a UN-recognized charity, bolstering educational programs for underserved children.

A new cell-free therapy for the fatal lung disease IPF is heading to clinical trials, thanks to a key manufacturing partnership. Here's what it means.

Chinese insurtech Huize is cutting back on financial reports to focus on strategy, but its latest data shows a complex picture of soaring premiums and slowing new user growth.

Global asset manager Patria Investments creates a new COO role and shuffles its finance leadership in a strategic move to scale operations globally.

Launching this Christmas, 'The Resurrection Coin' blends faith with Web3 to fund a new film, but faces scrutiny over its regulatory claims.

After a series of operational disasters and market pressures, materials giant Ascend emerges from Chapter 11 with a clean slate and a plan to dominate.

Quebec pauses its controversial Bill 2 after a landmark deal with family doctors. The agreement replaces penalties with incentives, but what does it mean?

Securities processors have filed a plan to extend trading to nearly 24 hours a day, a move set to transform Wall Street but posing huge tech hurdles.

Charlesbank's strategic funding validates HBox’s 'clinic within a clinic' model, aiming to revolutionize care for high-risk chronic conditions.

Fortune 500 giant ARKO Corp. plans to take its petroleum wholesale business public, a strategic split aimed at unlocking value and focusing growth.

With a star-studded 2026 lineup and rapid global expansion, Barco's advanced HDR Lightsteering technology is poised to become the new premium cinema standard.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.

A cancer research firm is betting its future on Zcash, recruiting the crypto's top minds. Is this the start of institutional adoption for privacy coins?

Researchers at Kanazawa University have developed engineered nanoparticles that can reprogram rogue immune cells, offering a targeted therapy for autoimmune diseases.

T'way Air launches aggressive year-end deals for Seoul and Jeju, sparking a price war among low-cost carriers on the popular Singapore-Korea travel route.

Tech billionaire and commercial astronaut Jared Isaacman is the new NASA chief. Can his entrepreneurial vision and private space experience reshape the agency?